Diagnostics for Informative Censoring in Trials of Schizophrenia Therapy

被引：0
|
作者：
Jackson, John [1 ]
Schnellinger, Erin [2 ]
Valeri, Linda [3 ]
Henderson, David [4 ]
Koenen, Karestan [2 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Harvard Univ, Cambridge, MA 02138 USA
[3] Harvard Med Sch, McLean Hosp, Boston, MA USA
[4] Boston Univ, Boston, MA 02215 USA
来源：
BIOLOGICAL PSYCHIATRY | 2017年 / 81卷 / 10期
关键词：
transparency; non-adherence; data visualization; dropout; censoring;
D O I：
10.1016/j.biopsych.2017.02.096
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
84
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [1] Diagnostics for informative censoring: Application to antipsychotic trials with high dropout rates
    Jackson, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 7 - 8
  • [2] Informative censoring - a neglected cause of bias in oncology trials
    Templeton, Arnoud J.
    Amir, Eitan
    Tannock, Ian F.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (06) : 327 - 328
  • [3] Informative censoring — a neglected cause of bias in oncology trials
    Arnoud J. Templeton
    Eitan Amir
    Ian F. Tannock
    Nature Reviews Clinical Oncology, 2020, 17 : 327 - 328
  • [4] Problems in dealing with missing data and informative censoring in clinical trials
    Weichung Joseph Shih
    Current Controlled Trials in Cardiovascular Medicine, 2002, 3
  • [5] Problems in dealing with missing data and informative censoring in clinical trials
    Shih, WCJ
    CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2002, 3 (1):
  • [6] Informative censoring in externally controlled clinical trials: a potential source of bias
    Gupta, T. Rudra
    Schwartz, D. E.
    Saha, R.
    Wen, P. Y.
    Rahman, R.
    Trippa, L.
    ESMO OPEN, 2025, 10 (01)
  • [7] A MODEL FOR INFORMATIVE CENSORING
    LINK, WA
    JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1989, 84 (407) : 749 - 752
  • [8] Informative Censoring Index: Quantifying the Potential for Informative Censoring in As-Treated Analyses
    Castillo, Wendy Camelo
    Sturmer, Til
    Funk, Michele Jonsson
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 393 - 394
  • [9] Post-protocol therapy and informative censoring in the CANDOR study
    Usmani, Saad Z.
    Li, Chuang
    Obreja, Mihaela
    Dimopoulos, Meletios
    LANCET ONCOLOGY, 2022, 23 (03): : E98 - E98
  • [10] Impact of informative censoring on estimation and testing in randomized trials with delayed treatment effects
    Lin, Jingyi
    Zhao, Yujie
    Chen, X. Gregory
    Donica, Margarita
    Leon, Larry
    Trinquart, Ludovic
    Wan, Shuyan Sabrina
    CONTEMPORARY CLINICAL TRIALS, 2025, 152
12345